(PharmaNewsWire.Com, January 20, 2018 ) According to the report “ Europe Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast. The increasing prevalence of the disease and its fatal affects have stimulated its growth.
Sepsis Diagnosis is the rise as the incidence rate and prevalence of sepsis is on the rise. Sepsis is a serious illness condition occurring when the body reacts to a foreign body infection, be it bacterial, viral, fungal or parasitic. It is one of the most death causing disease in hospitals. Infection leads to organ dysfunction or failure and systemic inflammation. Its symptoms are hypertension, high body temperature, shivering and high heart rate.
Factors like high incidence rates of hospital acquired infections, rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures and increasing number of product approvals driving the market forward. Yet, factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to obstruct the growth of market.
The Europe Sepsis Diagnostics market is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal. Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry. Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing.
Based on Geographical analysis the market is separated into regions of U.K., Germany, France, Italy and Spain. U.K. is leading the market while Germany is at second place. Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped U.K. dominate the market. Germany is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region. Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: